Cargando…
Sipa1 deficiency unleashes a host-immune mechanism eradicating chronic myelogenous leukemia-initiating cells
Chronic myelogenous leukemia (CML) caused by hematopoietic stem cells expressing the Bcr-Abl fusion gene may be controlled by Bcr-Abl tyrosine kinase inhibitors (TKIs). However, CML-initiating cells are resistant to TKIs and may persist as minimal residual disease. We demonstrate that mice deficient...
Autores principales: | Xu, Yan, Ikeda, Satoshi, Sumida, Kentaro, Yamamoto, Ryusuke, Tanaka, Hiroki, Minato, Nagahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834470/ https://www.ncbi.nlm.nih.gov/pubmed/29500416 http://dx.doi.org/10.1038/s41467-018-03307-8 |
Ejemplares similares
-
Global Thrombosis Test: Occlusion by Coagulation or SIPA?
por: Clavería, Viviana, et al.
Publicado: (2021) -
Rap Signaling in Normal Lymphocyte Development and Leukemia Genesis
por: Minato, Nagahiro
Publicado: (2009) -
Extramedullary blast crisis of chronic myelogenous leukemia as an initial presentation()
por: Tsukamoto, Shokichi, et al.
Publicado: (2013) -
Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia
por: Lei, Hu, et al.
Publicado: (2021) -
Chronic myelogenous leukemia in Libya
por: Mehdi, Itrat, et al.
Publicado: (2012)